Zenas BioPharma announced inducement grants of stock options and restricted stock units to newly hired employees under Nasdaq Listing Rule 5635(c)(4). The Compensation Committee granted non-qualified stock options to purchase an aggregate of 100,000 shares of common stock and an aggregate of 78,075 restricted stock units on June 15, 2026. The stock options have a ten-year term and an exercise price of $18.71 per share, vesting over four years with 25% after one year and the remainder in 36 equal monthly installments. The restricted stock units vest in four equal annual installments beginning June 15, 2027. The awards were made as an inducement material to the employees' entry into employment with the company.
Zenas BioPharma, Inc. Common StockInducement equity grants to new employees; dilutive but standard hiring practice, no material impact on operations.